Kimura's Disease Finding on Ocular Adnexal Mass
Downloads
Introduction: Kimura's disease is an unknown chronic lymphoproliferative inflammatory disease affecting the skin, soft tissues, and lymph nodes. Until September 2020, only 200 cases of Kimura's disease were reported worldwide, however, their exact incidence is unknown. Here, we are interested in reporting a patient with Kimura's disease of the ocular adnexa due to its rarity and to enhance the knowledge of ophthalmologists about confirming the diagnosis of Kimura's disease. Case Presentation: A 40-year-old female presented with a chief complaint of a mass on her left nasal orbit for the last year. The mass gradually increased for six months, and it was painless. The systemic laboratory workup revealed eosinophilia and increased serum IgE. Contrast CT-Scan revealed a benign tumor, suspect dermoid cyst. She underwent surgery, and the histopathologic showed Kimura's disease. The patient was followed up on a scheduled basis, and there was no recurrence during four months of monitoring. Conclusions: A clinical, systemic laboratory, and histopathological examination is required to confirm the diagnosis of Kimura's ocular adnexa disease and determine the best therapy for the patient due to the high recurrence rate. Combining surgical excision with postoperative radiation is recommended as the most effective treatment in terms of controlling the residual lesion and minimizing the recurrence rate while causing the fewest side effects. Eosinophil screening regularly is advised to evaluate the recurrence rate.
Buder K, Ruppert S, Trautmann A, Bröcker E-B, Goebeler M, Kerstan A. Angiolymphoid hyperplasia with eosinophilia and Kimura's disease - A clinical and histopathological comparison. J Dtsch Dermatol Ges 2014;12:224–228. https://doi.org/10.1111/ddg.12257_suppl.
Kottler D, Barète S, Quéreux G, Ingen-Housz-Oro S, Fraitag S, Ortonne N, et al. Retrospective multicentric study of 25 Kimura disease patients: Emphasis on therapeutics and shared features with cutaneous IgG4-related disease. Dermatology 2015;231:367–377. https://doi.org/10.1159/000439346.
Sun Q-F, Xu D-Z, Pan S-H, Ding J-G, Xue Z-Q, Miao C-S, et al. Kimura disease: Review of the literature. Intern Med J 2008;38:668–672. https://doi.org/10.1111/j.1445-5994.2008.01711.x.
AlGhamdi FE, Al-Khatib TA, Marzouki HZ, AlGarni MA. Kimura disease: No age or ethnicity limit. Saudi Med J 2016;37:315–319. https://doi.org/10.15537/smj.2016.3.14448.
Farooqui F, Rehman IU, Waseem S, Ullah I, Jehan M, Asghar MS. Kimura's disease and its masquerade with a malignancy: A case report. Ann Med Surg (Lond) 2022;78:103864. https://doi.org/10.1016/j.amsu.2022.103864.
Chen Q-L, Dwa S, Gong Z-C, Abasi K, Ling B, Liu H, et al. Kimura's disease: Risk factors of recurrence and prognosis. Int J Clin Exp Med 2015;8:21414–21420.
Zou A, Hu M, Niu B. Comparison between Kimura's disease and angiolymphoid hyperplasia with eosinophilia: Case reports and literature review. J Int Med Res 2021;49:3000605211040976. https://doi.org/10.1177/03000605211040976.
Chen H, Thompson LDR, Aguilera NSI, Abbondanzo SL. Kimura disease: A clinicopathologic study of 21 cases. Am J Surg Pathol 2004;28:505–513. https://doi.org/10.1097/00000478-200404000-00010.
Su S, Chen X, Li J, Yu J, Zhang L. Kimura's disease with membranoproliferative glomerulonephritis: A case report with literature review. Ren Fail 2019;41:126–130. https://doi.org/10.1080/0886022X.2019.1584115.
Kimm H, Szeto C. Eosinophilic hyperplastic lymphogranuloma, comparison with Mikulicz's disease. Proc Chin Med Soc 1937;329.
Kimura T, Yoshimura S, Ishikawa E. On the unusual granulation combined with hyperplastic changes oflymphatic tissues. Trans Soc Pathol Jpn 1948;37:179–180.
Wells GC, Whimster IW. Subcutaneous angiolymphoid hyperplasia with eosinophilia. Br J Dermatol 1969;81:1–14. https://doi.org/10.1111/j.1365-2133.1969.tb15914.x.
Agrawal S, Sen S, Sabu S, Modaboyina S, Bajaj MS, Das D. Bilateral orbital Kimura's disease: A case report and brief review of literature. Indian J Ophthalmol 2022;70:2737–2738. https://doi.org/10.4103/ijo.IJO_2648_21.
Kim WJ, Kim HK. Current concepts of Kimura disease: Pathophysiology and evolution of treatment. Arch Craniofac Surg 2022;23:249–255. https://doi.org/10.7181/acfs.2022.01053.
Monzen Y, Kiya K, Nishisaka T. Kimura's disease of the orbit successfully treated with radiotherapy alone: A case report. Case Rep Ophthalmol 2014;5:87–91. https://doi.org/10.1159/000360789.
Angelina A, Retnani DP, Ulfaningtyas K. Laporan kasus: Tumor parotis residif dengan diagnosis histopatologi suatu penyakit kimura. Majalah Kesehatan 2022;9:43–49. https://doi.org/10.21776/ub.majalahkesehatan.2022.009.01.6.
Sakamoto M, Komura A, Nishimura S. Hematoserological analysis of Kimura's disease for optimal treatment. Otolaryngol Head Neck Surg 2005;132:159–160. https://doi.org/10.1016/j.otohns.2004.04.030.
Chang AR, Kim K, Kim HJ, Kim IH, Park C Il, Jun YK. Outcomes of Kimura's disease after radiotherapy or nonradiotherapeutic treatment modalities. Int J Radiat Oncol Biol Phys 2006;65:1233–1239. https://doi.org/10.1016/j.ijrobp.2006.02.024.
Nakahara C, Wada T, Kusakari J, Kanemoto K, Kinugasa H, Sibasaki M, et al. Steroid-sensitive nephrotic syndrome associated with Kimura disease. Pediatr Nephrol 2000;14:482–485. https://doi.org/10.1007/s004670050798.
Ye P, Ma D-Q, Yu G-Y, Gao Y, Peng X. Comparison of the efficacy of different treatment modalities for Kimura's disease. Int J Oral Maxillofac Surg 2017;46:350–354. https://doi.org/10.1016/j.ijom.2016.08.013.
Hareyama M, Oouchi A, Nagakura H, Asakura K, Saito A, Satoh M, et al. Radiotherapy for Kimura's disease: The optimum dosage. Int J Radiat Oncol Biol Phys 1998;40:647–651. https://doi.org/10.1016/s0360-3016(97)00813-4.
Copyright (c) 2024 Nonidha Tiendie, Susy Fatmariyanti, Ridholia Ridholia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Vision Science and Eye Health Journal by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.
